Information about Spica Therapeutics
My details
*
*
*

Spica Therapeutics (SA)

Company information

Status
Active

Enterprise number

BE1012.800.853

VAT liability
Yes
Established
26-08-2024
Last balance sheet year
2025
Company size
Medium-sized 0,7 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Spica Therapeutics

2025
Profit/Loss -2,731,925
Equity 6,155,327
Gross margin -1,005,987
Employees 0.7

Publications from Spica Therapeutics

Date Publication
13-03-2026 Articles of Association (Translation, Coordination, Other Modifications, …) - Capital - Shares (NL)
11-06-2025 Articles of Association (Translation, Coordination, Other Modifications, …) - Registered Office - Capital - Shares - Resignations - Appointments (NL)
12-05-2025 Resignations - Appointments (NL)
19-12-2024 Miscellaneous (FR)
30-09-2024 Miscellaneous (FR)

Frequently asked questions

What is the VAT number of Spica Therapeutics?
The VAT number of Spica Therapeutics is BE 1012.800.853.
Wat is the PEPPOL ID of Spica Therapeutics?
The PEPPOL ID of Spica Therapeutics is 0208:1012800853. Log in or start a free trial to see the full overview.
When was Spica Therapeutics founded?
Spica Therapeutics was founded on 26-08-2024.
What is the address of Spica Therapeutics?
The current registered office of Spica Therapeutics is located at Uitbreidingstraat 66/3, 2600 Antwerpen.
When was the last time Spica Therapeutics filed their annual financial statements?
The most recent financial statements of Spica Therapeutics were filed on 23-05-2026.
How many employees does Spica Therapeutics have?
There are 0,7 FTEs working at Spica Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Spica Therapeutics?
At the time of its most recent financial statements, Spica Therapeutics did not publish any turnover figures. Spica Therapeutics reported a gross margin of -€1,005,987.25.